[Federal Register: December 21, 1998 (Volume 63, Number 244)]
[Notices]               
[Page 70443]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr21de98-121]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

 
Issuer Delisting; Notice of Application to Withdraw from Listing 
and Registration; (Medco Research, Inc., Common Stock, $.001 Par Value; 
Common Stock Purchase Rights) File No. 1-9771

December 14, 1998.
    Medco Research, Inc. (``Company'') has filed an application with 
the Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and Rule 
12d2-2(d) promulgated thereunder, to withdraw the above specified 
securities (``Securities'') from listing and registration on the 
American Stock Exchange, Inc. (``Amex'' or ``Exchange'').
    The reasons cited in the application for withdrawing the Securities 
from listing and registration include the following:
    The Securities of the Company have been listed for trading on the 
Amex and, pursuant to a Registration Statement on Form 8-A which became 
effective on December 2, 1998, on the New York Stock Exchange, Inc. 
(``NYSE''). Trading of the Company's Securities on the NYSE commenced 
at the opening of business on December 2, 1998, and concurrently 
therewith the stock was suspended from trading on the Amex.
    The Company has complied with Rule 18 of the Amex by filing with 
the Exchange a certified copy of resolutions adopted by the Company's 
Board of Directors authorizing the withdrawal of its Securities from 
listing on the Amex and by setting forth in detail to the Exchange the 
reasons for the proposed withdrawal, and the facts in support thereof. 
In making the decision to withdraw its Securities from listing on the 
Amex, the Company considered the avoidance of listing on dual markets.
    The Exchange has informed the Company that it has no objection to 
the withdrawal of the Company's Securities from listing on the Amex.
    This application relates solely to the withdrawal from listing of 
the Company's Securities from the Amex and shall have no effect upon 
the continued listing of the Securities on the NYSE.
    By reason of Section 12(b) of the Act and the rules and regulations 
of the Commission thereunder, the Company shall continue to be 
obligated to file reports under Section 13 of the Act with the 
Commission and the NYSE.
    Any interested person may, on or before January 6, 1999, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, N.W., Washington, D.C. 20549, facts bearing upon whether 
the application has been made in accordance with the rules of the 
Exchange and what terms, if any, should be imposed by the Commission 
for the protection of investors. The Commission, based on the 
information submitted to it, will issue an order granting the 
application after the date mentioned above, unless the Commission 
determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 98-33664 Filed 12-18-98; 8:45 am]
BILLING CODE 8010-01-M